Sentences with phrase «public medical device company»

That grew into a business called Vortex Medical Inc., which in turn was sold to a public medical device company for $ 55 million in 2012 and was recently featured on the medical TV drama Grey's Anatomy.

Not exact matches

«We've responded to the competitive environment by focusing on industries that are currently out of favor with the public - equity market, like biotech, medical devices, and early - stage information - technology companies,» says Patrick Boroian, a general partner at Sprout, which is the New York City - based venture - capital affiliate of financial - services giant Donaldson, Lufkin & Jenrette.

Andrew's primary responsibility at RA Capital is to evaluate public and private investments in companies developing drugs, medical devices, diagnostics, and research tools, with a focus on new company formation.

She joined Wellcap Partners as an assistant portfolio manager, followed by a role at Boston Avenue Capital as a portfolio manager, during which time she took a role as interim Chief Operations Officer of Compumed, a public company specializing in medical devices for osteoporosis testing.

Though this simple medical device contains only about $ 1 of the drug epinephrine, the company that sells it, Mylan, earned the public's enmity and lawmakers» scrutiny after ratcheting up prices to $ 609 a box.

HOOPP was an initial private equity investor at Teranet's founding, remained the largest shareholder when the company was taken public on the TSX, and eventually sold its stake into a $ 2.0 billion take - over bid in 2008; Ducati Motorcycle Company, initially an NYSE / Milan listed Italian sport motorcycle manufacturer, which was the subject of a deleveraging capital increase, taken private and eventually sold to Volkswagen / Audi Group in 2012 for US$ 1.1 billion; and Novadaq Technologies Inc., a medical devices company in which HOOPP was the largest private investor, with such company completing an initial public offering on the TSX in 2005 and which continues today with a market capitalization in excess of $ 730 mcompany was taken public on the TSX, and eventually sold its stake into a $ 2.0 billion take - over bid in 2008; Ducati Motorcycle Company, initially an NYSE / Milan listed Italian sport motorcycle manufacturer, which was the subject of a deleveraging capital increase, taken private and eventually sold to Volkswagen / Audi Group in 2012 for US$ 1.1 billion; and Novadaq Technologies Inc., a medical devices company in which HOOPP was the largest private investor, with such company completing an initial public offering on the TSX in 2005 and which continues today with a market capitalization in excess of $ 730 mCompany, initially an NYSE / Milan listed Italian sport motorcycle manufacturer, which was the subject of a deleveraging capital increase, taken private and eventually sold to Volkswagen / Audi Group in 2012 for US$ 1.1 billion; and Novadaq Technologies Inc., a medical devices company in which HOOPP was the largest private investor, with such company completing an initial public offering on the TSX in 2005 and which continues today with a market capitalization in excess of $ 730 mcompany in which HOOPP was the largest private investor, with such company completing an initial public offering on the TSX in 2005 and which continues today with a market capitalization in excess of $ 730 mcompany completing an initial public offering on the TSX in 2005 and which continues today with a market capitalization in excess of $ 730 million.

As a young professional, he began his career in medical devices in the 1960's as a salesman, and has since launched seven public companies.

Julie Christina Grew has a Master's degree in public health and is earning an industrial Ph.D. with the University of Copenhagen and the medical device company Medtronic, whose world headquarters is in Minneapolis, Minnesota.

Dave's experience includes start - up to Fortune 1000 companies, public and private companies, domestic and international, and includes experience in consumer and industrial markets, life science, pharmaceuticals and medical device companies, technology, real estate and banking and finance.

Before IGC, Abhijeet spent 10 years as a Managing Member of EGS Healthcare Capital Partners, a venture capital firm focusing on private and public investments in biotechnology, specialty pharmaceutical and medical device companies.

We represent public and private high - growth companies of all sizes in the technology, health care, life sciences, consumer products, media and medical devices industries.

These include start - up enterprises and ongoing private and public companies engaged in any number of fields such as biotechnology, medical devices, software and computers, electronics, health care, telecommunications, banking and financial services.

When pharmaceutical companies promote drugs and medical devices, or take advantage of «off - label» use by repurposing a medicine's original treatment without the necessary testing, it puts the public at risk.

Bill Stanger, senior corporate counsel at Vancouver - based specialty pharmaceutical and medical device company Angiotech Pharmaceuticals Inc. says that the difficulties of being a public company, including disclosure requirements and shareholder issues, are something that are taking up an increasing amount of time.

Managed capitalization and corporate activities of public and private medical device companies.